Search Share Prices
GSK Shares - JPMorgan Chase & Co. Reiterates GBX 1,740 Price Target for GlaxoSmithKline (LON:GSK)
GlaxoSmithKline (LON:GSK – Get Rating) received a GBX 1,740 ($22.64) price target from equities researchers at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday, ...
GlaxoSmithKline (LON:GSK) Given a GBX 1,740 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. set a GBX 1,740 ($22.67) target price on GlaxoSmithKline (LON:GSK – Get Rating) in a research report released on Wednesday morning, Borsen Zeitung reports. Other equities research ...
JPMorgan Chase & Co. Analysts Give GlaxoSmithKline (LON:GSK) a GBX 1,740 Price Target
JPMorgan Chase & Co. set a GBX 1,740 ($22.67) price objective on GlaxoSmithKline (LON:GSK – Get Rating) in a research note issued to investors on Wednesday, Borsen Zeitung reports. Several other ...
How Immutep Treats Head & Neck Cancer
ShareCafe spoke with Marc Voigt, CEO of local biotech Immutep, about the progress his company is making specifically in the area of head and neck cancer treatments.
GlaxoSmithKline (LON:GSK) Given “Equal Weight” Rating at Barclays
Barclays restated their equal weight rating on shares of GlaxoSmithKline (LON:GSK – Get Rating) in a report issued on Monday, MarketBeat.com reports. The brokerage currently has a GBX 1,675 ($21.83) ...